Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Poolbeg Pharma (POLB) Share Price

Price 8.70p on 15-09-2026 at 11:55:08
Change 0.30p 3.57%
Buy 8.80p
Sell 8.60p
Last Trade: Sell 19.00 at 8.60p
Day's Volume: 174,619
Last Close: 8.40p
Open: 8.40p
ISIN: GB00BKPG7Z60
Day's Range 8.40p - 8.70p
52wk Range: 3.30p - 9.00p
Market Capitalisation: £66.42m
VWAP: 8.56813p
Shares in Issue: 763.44m

Poolbeg Pharma (POLB) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Sell* 19 8.60p Ordinary
12:52:33 - 15-Sep-26
Sell* 1,000 8.60p Ordinary
12:51:09 - 15-Sep-26
Sell* 10,000 8.61p Ordinary
12:26:44 - 15-Sep-26
Sell* 750 8.60p SI Trade
12:26:35 - 15-Sep-26
Buy* 20 8.80p SI Trade
12:26:35 - 15-Sep-26
Sell* 4,000 8.60p SI Trade
12:26:35 - 15-Sep-26
Sell* 40,387 8.65p Ordinary
11:56:27 - 15-Sep-26
Sell* 5,742 8.65p Ordinary
11:32:01 - 15-Sep-26
Sell* 5,636 8.50p Ordinary
11:09:43 - 15-Sep-26
Sell* 27,500 8.522p Ordinary
10:57:11 - 15-Sep-26
See more Poolbeg Pharma trades

Poolbeg Pharma (POLB) Share Price History

Time period:
to
Date Open High Low Close Volume
14th Sep 2026 (Mon) 8.35 8.40 8.40 8.40 849,409
11th Sep 2026 (Fri) 8.40 8.30 8.30 8.30 2,518,220
10th Sep 2026 (Thu) 8.35 8.40 8.35 8.40 1,298,624
9th Sep 2026 (Wed) 8.40 8.40 8.35 8.35 331,572
8th Sep 2026 (Tue) 8.35 8.40 8.35 8.40 1,684,535
7th Sep 2026 (Mon) 8.25 8.30 8.30 8.30 1,407,514
4th Sep 2026 (Fri) 8.40 8.30 8.25 8.25 1,473,544
3rd Sep 2026 (Thu) 8.25 8.58 8.58 8.58 4,492,668
2nd Sep 2026 (Wed) 8.35 8.50 8.24 8.24 1,126,082
1st Sep 2026 (Tue) 8.45 8.55 8.35 8.35 2,166,534
31st Aug 2026 (Mon) 8.60 8.60 8.60 8.60 0
28th Aug 2026 (Fri) 8.45 8.60 8.60 8.60 2,290,224
27th Aug 2026 (Thu) 8.65 8.40 8.40 8.40 3,010,250
26th Aug 2026 (Wed) 8.60 8.60 8.60 8.60 1,816,136
25th Aug 2026 (Tue) 8.50 8.70 8.60 8.60 4,910,287
24th Aug 2026 (Mon) 8.80 8.80 8.50 8.50 3,090,189
21st Aug 2026 (Fri) 8.95 8.95 8.80 8.80 1,909,745
20th Aug 2026 (Thu) 8.65 9.00 8.65 9.00 2,656,050
19th Aug 2026 (Wed) 8.65 8.70 8.65 8.65 1,532,312
18th Aug 2026 (Tue) 8.60 8.80 8.80 8.80 2,166,117
17th Aug 2026 (Mon) 8.50 8.70 8.55 8.70 1,101,574
See more Poolbeg Pharma price history

Poolbeg Pharma (POLB) Regulatory News

Date Source Headline
14th Sep 2026 11:58 am RNS Notification of Major Holdings
3rd Sep 2026 7:00 am RNS-R Key Conference Participation in September 2026
23rd Jul 2026 11:05 am RNS Notification of major holdings
22nd Jul 2026 7:00 am RNS Notification of Major Holdings
21st Jul 2026 7:00 am RNS-R Notice of Allowance for POLB 001 patent in Israel
14th Jul 2026 7:00 am RNS Placing to raise £3.5 million
13th Jul 2026 7:00 am RNS First patient dosed in POLB 001 TOPICAL trial
30th Jun 2026 7:00 am RNS-R POLB 001 patent granted in South Africa
16th Jun 2026 7:05 am RNS European patent granted for POLB 001 in CRS
16th Jun 2026 7:00 am RNS PDMR Notification
See more Poolbeg Pharma regulatory news

Poolbeg Pharma (POLB) Share News

TRADING UPDATES: Zenith private placement; CyanConnode revised offer

21st Jul 2026 19:34

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More

IN BRIEF: Poolbeg Pharma raises GBP3.5 million in share placing

15th Jul 2026 06:59

Poolbeg Pharma PLC - London-based biopharmaceutical firm focused on cancer immunotherapy - Raises GBP3.5 million from a placing of 58.3 million new shares at 6 pence each. The placing price is a discount of 16% from the stock's closing market price on Monday. The funds will be used to fund two drug trials through to completion, extending Poolbeg's cash runway into the second quarter of 2028. The share placing is run by broker Oak Securities. "This successful fundraise is a great market endorsement of Poolbeg, our strategy and pipeline," says Chief Executive Officer Jeremny Skillington. "Not only does it extend our expected cash runway into Q2 2028, but it strengthens the company's position in ongoing partnering discussions." Read More

WINNERS & LOSERS: Ironveld's plant in production; Headlam revenue down

14th Jul 2026 11:16

(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Tuesday. Read More

TRADING UPDATES: Zenith Energy in Rome buy; Concurrent revenue rises

13th Jul 2026 11:42

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News: Read More

EARNINGS AND TRADING: IG Design restores dividend and launches buyback

16th Jun 2026 15:32

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More

See more Poolbeg Pharma news
FTSE 100 Latest
Value10,660.45
Change-37.12

Login to your account

Forgot Password?

Not Registered